These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 8546145

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Hepatic enzymes of tyrosine metabolism in tyrosinemia II.
    Goldsmith LA, Thorpe J, Roe CR.
    J Invest Dermatol; 1979 Dec; 73(6):530-2. PubMed ID: 41876
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Novel and recurrent tyrosine aminotransferase gene mutations in tyrosinemia type II.
    Hühn R, Stoermer H, Klingele B, Bausch E, Fois A, Farnetani M, Di Rocco M, Boué J, Kirk JM, Coleman R, Scherer G.
    Hum Genet; 1998 Mar; 102(3):305-13. PubMed ID: 9544843
    [Abstract] [Full Text] [Related]

  • 30. Hereditary tyrosinaemia type II in a consanguineous Ashkenazi Jewish family: intrafamilial variation in phenotype; absence of parental phenotype effects on the fetus.
    Chitayat D, Balbul A, Hani V, Mamer OA, Clow C, Scriver CR.
    J Inherit Metab Dis; 1992 Mar; 15(2):198-203. PubMed ID: 1356171
    [Abstract] [Full Text] [Related]

  • 31. Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome).
    Goldsmith LA.
    Exp Cell Biol; 1978 Mar; 46(1-2):96-113. PubMed ID: 23331
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Bilateral dendritic pseudokeratitis (Richner-Hanhart syndrome)].
    Sundmacher R.
    Klin Monbl Augenheilkd; 1977 Jan; 170(1):84-8. PubMed ID: 139500
    [Abstract] [Full Text] [Related]

  • 36. The effect of diet on the ophthalmological, clinical and biochemical aspects of Richner-Hanhart syndrome: a morphological ultrastructural study of the cornea and the conjunctiva.
    Sammartino A, Cerbella R, Cecio A, De Crecchio G, Federico A, Fronterre A.
    Int Ophthalmol; 1987 Aug; 10(4):203-12. PubMed ID: 3654059
    [Abstract] [Full Text] [Related]

  • 37. [Two cases of Richner-Hanhart syndrome (oculocutaneous tyrosinemia)].
    Bygum A, Brandrup F, Gade EF, Lund AM, Christensen E.
    Ugeskr Laeger; 2008 Feb 18; 170(8):655. PubMed ID: 18364160
    [Abstract] [Full Text] [Related]

  • 38. Painful keratoderma and photophobia: hallmarks of tyrosinemia type II.
    Rabinowitz LG, Williams LR, Anderson CE, Mazur A, Kaplan P.
    J Pediatr; 1995 Feb 18; 126(2):266-9. PubMed ID: 7844676
    [Abstract] [Full Text] [Related]

  • 39. Pseudodendritic keratitis and systemic tyrosinemia.
    Charlton KH, Binder PS, Wozniak L, Digby DJ.
    Ophthalmology; 1981 Apr 18; 88(4):355-60. PubMed ID: 6454871
    [Abstract] [Full Text] [Related]

  • 40. Parahydroxyphenylpyruvicacidemia in tyrosinosis.
    Jaiswal RB, Bhai I, Daginawala HF, Nath N, Nath MC.
    Indian Pediatr; 1978 Nov 18; 15(11):893-9. PubMed ID: 36347
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.